Determinants of Metabolic Syndrome and Type 2 Diabetes in the Absence of Obesity: The Jackson Heart Study

被引:2
|
作者
Mongraw-Chaffin, Morgana [1 ]
Saldana, Santiago [2 ]
Carnethon, Mercedes R. [3 ]
Chen, Haiying [2 ]
Effoe, Valery [4 ]
Golden, Sherita Hill [5 ]
Joseph, Joshua [6 ]
Kalyani, Rita R. [5 ]
Bertoni, Alain G. [1 ]
机构
[1] Wake Forest Sch Med, Dept Epidemiol & Prevent, Med Ctr Blvd, Winston Salem, NC 27157 USA
[2] Wake Forest Sch Med, Dept Biostat & Data Sci, Winston Salem, NC 27157 USA
[3] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA
[4] Morehouse Sch Med, Div Cardiol, Atlanta, GA 30310 USA
[5] Johns Hopkins Univ, Sch Med, Div Endocrinol Diabet & Metab, Baltimore, MD USA
[6] Ohio State Univ, Wexner Med Ctr, Div Endocrinol Diabet & Metab, Columbus, OH 43210 USA
关键词
type; 2; diabetes; metabolic syndrome; visceral fat normal weight; African American; BODY-MASS INDEX; CARDIOMETABOLIC RISK-FACTORS; SUBCUTANEOUS ADIPOSE-TISSUE; VISCERAL FAT; CARDIOVASCULAR-DISEASE; NORMAL-WEIGHT; AFRICAN-AMERICANS; HEALTHY OBESITY; CONSEQUENCES; ACCUMULATION;
D O I
10.1210/jendso/bvac059
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Multiple studies suggest that adults who were normal weight at diabetes diagnosis are at higher risk for all-cause mortality than those who had overweight or obesity at diagnosis. Objective: While obesity is a known risk factor for cardiometabolic disease, differences in body fat distribution in those without obesity are understudied, especially in African Americans. Methods: In 1005 participants of the Jackson Heart Study, without cardiovascular disease at baseline, we used logistic regression to investigate the longitudinal association of body fat distribution by CT scan with metabolic syndrome (MetS) or type 2 diabetes (T2D). We used the harmonized International Diabetes Federation criteria to define MetS. We included only normal weight or overweight participants (BMI: 18.5 to < 30.0 kg/m(2)). We created separate models for MetS and T2D adjusted for a standard set of covariates. We excluded participants with prevalent MetS or T2D, respectively in sensitivity. Results: Higher visceral fat, subcutaneous fat, BMI, and insulin resistance (HOMA-IR) were significantly associated with MetS and T2D after adjustment. Visceral fat was strongly associated with both outcomes (MetS OR = 2.07 [1.66-2.68]; T2D OR = 1.51 [1.21-1.88]), and the association for MetS persisted in the normal weight only group. Estimates were robust to sensitivity analysis and were only modestly mediated by insulin resistance. Physical activity was not associated with MetS or T2D. Conclusion: Visceral fat is strongly associated with developing MetS, even in normal weight individuals, suggesting that excess visceral fat plays a role in cardiometabolic risk beyond that of overall adiposity and obesity in African Americans.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Determinants of Incident Metabolic Syndrome and Type 2 Diabetes in Normal Weight: The Jackson Heart Study
    Mongraw-Chaffin, Morgana
    Saldana, Santiago
    Carnethon, Mercedes R.
    Chen, Haiying
    Effoe, Valery S.
    Golden, Sherita H.
    Joseph, Joshua J.
    Kalyani, Rita R.
    Norwood, Arnita
    Bertoni, Alain G.
    CIRCULATION, 2018, 137
  • [2] Testosterone in Obesity, Metabolic Syndrome and Type 2 Diabetes
    Stanworth, Roger D.
    Jones, T. Hugh
    ADVANCES IN THE MANAGEMENT OF TESTOSTERONE DEFICIENCY, 2009, 37 : 74 - 90
  • [3] Magnesium in Obesity, Metabolic Syndrome, and Type 2 Diabetes
    Piuri, Gabriele
    Zocchi, Monica
    Della Porta, Matteo
    Ficara, Valentina
    Manoni, Michele
    Zuccotti, Gian Vincenzo
    Pinotti, Luciano
    Maier, Jeanette A.
    Cazzola, Roberta
    NUTRIENTS, 2021, 13 (02) : 1 - 17
  • [4] Relations Between Subclinical Disease Markers and Type 2 Diabetes, Metabolic Syndrome, and Incident Cardiovascular Disease: The Jackson Heart Study
    Xanthakis, Vanessa
    Sung, Jung Hye
    Samdarshi, Tandaw E.
    Hill, Alethea N.
    Musani, Solomon K.
    Sims, Mario
    Ghraibeh, Kamel A.
    Liebson, Philip R.
    Taylor, Herman A.
    Vasan, Ramachandran S.
    Fox, Ervin R.
    DIABETES CARE, 2015, 38 (06) : 1082 - 1088
  • [5] Magnesium in Type 2 Diabetes Mellitus, Obesity, and Metabolic Syndrome
    Barbagallo, Mario
    Veronese, Nicola
    Dominguez, Ligia J.
    NUTRIENTS, 2022, 14 (03)
  • [6] Central obesity, metabolic syndrome and type 2 diabetes mellitus
    Pusparini
    UNIVERSA MEDICINA, 2007, 26 (04) : 195 - 204
  • [7] Male Hypogonadism and Obesity, the Metabolic Syndrome, and Type 2 Diabetes
    Messer, C.
    Tamler, R.
    DIABETES STOFFWECHSEL UND HERZ, 2010, 19 (06): : 427 - 430
  • [8] The metabolic syndrome as predictor of type 2 diabetes - The San Antonio Heart Study
    Lorenzo, C
    Okoloise, M
    Williams, K
    Stern, MP
    Haffner, SM
    DIABETES CARE, 2003, 26 (11) : 3153 - 3159
  • [9] Natural Products for the Treatment of Obesity, Metabolic Syndrome, and Type 2 Diabetes
    Thounaojam, Menaka C.
    Nammi, Srinivas
    Jadeja, Ravirajsinh
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2013, 2013 : 1 - 2
  • [10] Prevalence of metabolic syndrome, obesity and diabetes type 2 in cryptogenic cirrhosis
    Tellez-Avila, Felix I.
    Sanchez-Avila, Francisco
    Garcia-Saenz-de-Sicilia, Mauricio
    Chavez-Tapia, Norberto C.
    Franco-Guzman, Ada M.
    Lopez-Arce, Gustavo
    Cerda-Contreras, Eduardo
    Uribe, Misael
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (30) : 4771 - 4775